Skip to main content

What the FDA labels say about taking them together

Lenalidomide and pembrolizumab

Lenalidomide's FDA label of March 24, 2023 names pembrolizumab in its warnings and precautions section; the pembrolizumab label PlainMeds reads does not name lenalidomide. The lenalidomide label: “Increased Mortality: Observed in patients with MM when pembrolizumab was added to dexamethasone and a thalidomide analogue.”

Check it at the source: the lenalidomide FDA label on DailyMed (effective March 24, 2023, Celgene Corporation); the pembrolizumab FDA label on DailyMed (effective July 10, 2026, Merck Sharp & Dohme LLC).

What does the lenalidomide label say about pembrolizumab?

Lenalidomide label, warnings and precautions

Increased Mortality: Observed in patients with MM when pembrolizumab was added to dexamethasone and a thalidomide analogue ( 5.7 ).

Source: FDA drug label (Revlimid), NDA021880 (Bristol Myers Squibb), as published by Celgene Corporation, effective March 24, 2023 (SPL set 5fa97bf5-28a2-48f1-8955-f56012d296be), via openFDA; the full label on DailyMed

What does the pembrolizumab label say about lenalidomide?

Pembrolizumab's label (effective July 10, 2026) does not name lenalidomide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (KEYTRUDA), Merck Sharp & Dohme LLC, effective July 10, 2026 (SPL set 9333c79b-d487-4538-a9f0-71b91a02b287), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

18Lenalidomide generic labelers
0Pembrolizumab generic labelers
LenalidomidePembrolizumab
Labeled forLeukemia, lymphoma and myeloma, AnemiaLung cancer, Colorectal cancer, Leukemia, lymphoma and myeloma, Breast cancer
Boxed warningYesNo
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?